Specific, high-affinity (Kd 0.6 nM), and saturable (3.3 fmol/mg of tissue, wet weight) binding of '25I-labeled [Sar',Ile8]angiotensin II to rat ovarian membranes was observed. Displacement of '25I-labeled [Sar',Ile8]angiotensin II binding to rat ovarian membranes by angiotensin II analogs and fragments resembled the potency order of these compounds on angiotensin II receptors in other tissues: [Sarl,1e8]angiotensin II > angiotensin II > des-Aspl-angiotensin II > angiotensin I > des-Asp',Arg2-angiotensin II.
The sequential processing of circulating angiotensinogen by renin (EC 3.4.23.15) and angiotensin I converting enzyme (EC 3.4.15.1) to yield the effector peptide angiotensin II (Ang II) is initiated by the release of the enzyme renin, primarily from the kidney (1) . Ang II formed in this way has multiple diverse physiological effects, including arteriolar vasoconstriction (1), aldosterone secretion (2, §), and induction of drinking behavior (3) . In addition to kidney-dependent intravascular Ang II formation, several other tissues-for example, the brain (4) and adrenal gland (5) -are potentially important local sites of production of Ang II, since they also contain the components of the renin-angiotensin system. Furthermore, several tissues that contain renin-angiotensin system components also contain specific cell surface Ang II receptors (6) . Thus, local Ang II production may be a significant autocrine or paracrine modulator of tissue function.
Prorenin, renin, angiotensinogen, and Ang II immunoreactivity (Ang II-ir) have been demonstrated in human ovarian follicular fluid (7, 8) . The presence ofangiotensin I converting enzyme has also been demonstrated on oocytes in the rabbit ovary (9) . These studies point toward a potentially important role of Ang II in the ovary, and thus they prompted us to look for Ang II receptors in the ovary (10) and to evaluate the nature of ovarian Ang II-ir. Our data show that the rat ovary is a target organ for Ang II and demonstrate the presence of the Ang II octapeptide in the rat ovary.
MATERIALS AND METHODS
Measurement of Ovarian and Plasma Ang II-ir. Female Sprague-Dawley rats (-200 g) were used in this study. Ang II-ir in ovaries and plasma (obtained from the initial 2 ml of trunk blood) was extracted by the method of Eng and Yalow (11) . 125I-labeled Ang II (1251-Ang II; 1000 cpm; New England Nuclear) was added at the beginning of the extraction to all samples for the estimation of recovery. The dried extracts were resuspended in 0.1% trifluoroacetic acid and were applied to a C18 Sep-Pak cartridge (Waters Associates) and the fraction eluting between 10% and 30% acetonitrile (containing 0.1% trifluoroacetic acid) was used for the estimation by radioimmunoassay (12) For autoradiographic studies, 20-gm-thick ovarian sections were cut in a cryostat at -16'C, thaw mounted onto slides, air-dried at room temperature, and stored at -230C. Sections were thawed for about 0.5 min at 350C, incubated for 30 min at 23°C in incubation buffer with 0.2% bovine albumin, and placed in incubation buffer containing 0.25 nM 125I_ [Sar',Ile8]Ang II and 0.2% bovine albumin for 1 hr at 23°C.
Alternate sections were placed in incubation buffer containing 1 A.M Ang II in addition to the 125I-[Sarl,11e8]Ang II and 0.2% bovine albumin to serve as control sections for measurement of nonspecific binding. The sections were then sequentially rinsed in ice-cold distilled water, incubation buffer, and distilled water, and subsequently dried under a stream of hot air. The sections were first apposed to film (Ultroffilm, LKB) for 3 to 4 days and then stained with hematoxylin and eosin (H&E).
RESULTS
Ang H-ir in the Rat Ovary. The level of Ang II-ir in the rat ovary (450 ± 200 pg/g of tissue, wet weight; n = 5) exceeds the concentration of this hormone in the plasma (16 ± 1.6 pg/ml; n = 5) by 8-to 75-fold. In bilaterally nephrectomized rats the levels of Ang II-ir in the ovary (243 ± 100 pg/g of tissue, wet weight; n = 4) or the plasma (22 ± 6 pg/ml; n = 4) were not less than those found in control rats. The recovery of 125I-Ang II added to the tissue at the time of extraction was consistently similar with ovaries (79 ± 1% for control; 83 + 2% for nephrectomy) and plasma (74 ± 2% for control; 80 + 3% for nephrectomy).
Under our chromatographic conditions, synthetic Ang II, Ang-(2-8), Ang-(3-8), and Ang-(4-8) were resolved as four clearly identifiable peaks (Fig. 1) (Fig. 4a) . Fig. 4b shows that considerable autoradiographic exposure occurred over the theca interna and granulosa cell layers. On the basis of the size distribution of large follicles throughout the estrus cycle in the rat (14) , the 600-to 700-,im-diameter follicles shown in Fig. 4 suggest that the ovary used to obtain the section was from a rat in diestrus-2 or proeF+'us.
DISCUSSION
These studies confirm and extend our preliminary observation of Ang II receptor binding in the rat ovary (10) . The simultaneous demonstration of Ang II in rat ovary, independent of the renal renin-angiotensin system, suggests that Ang II is an autocrine or paracrine regulator of ovarian function. Prorenin, renin, angiotensinogen, and Ang IT-ir have been demonstrated in human follicular fluid, which suggests the presence of a local renin-angiotensin system in the human ovary (7, 8) . The recent demonstration of angiotensinogen mRNA in the rat ovary by Ohkubo et al. (15) and our finding of high levels of Ang I-ir in the rat ovary support the concept of a local Ang II-forming system in the ovary of the rat. Chromatographic analysis of the total ovarian extract showed that over 90% of the Ang II-ir recovered eluted with the retention time of Ang II. Assuming similar recoveries of Ang II and its fragments, this indicates that ovarian Ang II-ir is primarily the octapeptide Ang II. The levels of Ang II-ir in the ovary were much higher than those found in an equivalent volume of plasma, indicating that Ang II-ir levels in the ovary are not due to simple contamination of this tissue with circulating Ang II. However, it is possible that the Ang II present in the ovary is sequestered by ovarian Ang II receptors and could therefore be derived in part from blood. Ang II-ir levels in the rat ovary ranged between 130 and 1210 pg/g oftissue, wet weight, and were much more variable than the levels found in plasma or those in other tissues such as the adrenal gland (data not shown). This variability was not due to differential recovery during the extraction procedures, since recovery of internal standard was consistent and high.
It is known that several components of the renin-angiotensin system, including Ang II receptors, fluctuate during the estrus cycle in rats. For example, in rats, plasma angiotensinogen increases and brain angiotensinogen decreases at estrus (16) . During diestrus, pituitary Ang II receptor density is highest and uterine Ang II receptor density is lowest (16, 17) , compared with the rest of the estrus cycle. The female rats used in our study were not selected with reference to the stage of the cycle. Thus, the variability in ovarian Ang II levels may be due to variations associated with the estrus cycle. 
